AVD(SZ:300939)2025-05-28 09:48Group 1: Company Overview - The company's overseas sales accounted for 41.38% of total revenue in 2024, with major markets including North America, Europe, and Asia [3] - The company employs 261 R&D personnel, representing 11.45% of the total workforce as of December 31, 2024 [4] Group 2: Sales and Market Strategy - The company primarily offers customized products to two main customer categories: end product manufacturers and technology service providers [3] - The impact of U.S. tariffs is minimal as direct exports to the U.S. are low; recent trade agreements have led to the cancellation of 91% of tariffs on Chinese goods [3] Group 3: Product Applications - In the medical health sector, the company's products are used in portable medical devices, medical instruments, and sports health applications [4] - In the automotive electronics sector, products are utilized in dashboards, central control panels, and rearview mirrors, with key clients including BYD and Nissan [4] Group 4: Future Plans and Investments - The company is constructing a production base in Thailand to enhance overseas manufacturing capabilities [3] - Plans for investment and acquisitions are aligned with the company's strategic goals, focusing on synergistic and high-potential projects [5] - The company has implemented a share buyback plan to support employee stock ownership and potential equity incentives [6] Group 5: Financial Policies - The company maintains a consistent cash dividend policy and has outlined a shareholder return plan for 2023-2025 [6] - The focus remains on long-term sustainable growth while enhancing shareholder value through stable profit distribution [6]